ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis"

  • Abstract Number: 1023 • ACR Convergence 2024

    Factors Associated with Delays in Dispensation and Insurance Denials of Janus Kinase Inhibitors

    Igor Dombrovsky1, Michael George2, Joshua Baker2 and Thomas Riley3, 1Pennsylvania Hospital, Philadephia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Hopsital of the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Access to Janus kinase inhibitors (JAKi) is controlled by insurance carriers through prior authorizations and the use of restricted formularies. We previously showed that…
  • Abstract Number: 1130 • ACR Convergence 2024

    Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease

    Melanie Hagen1, Laura Bucci1, Sebastian Boeltz2, Danae-Mona Noethling2, Tobias Rothe2, Maria Gabriella Raimondo1, Carlo Tur1, Andreas Wirsching1, Jochen Wacker1, Aline Bozec1, Georg Schett3 and Ricardo Grieshaber-Bouyer1, 1Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Bayern, Germany, 2Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, 3Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    Background/Purpose: B-cells and plasma cells are key drivers of systemic autoimmune diseases (AID). Recent data demonstrated preliminary safety and efficacy of using the CD3xCD19 bispecific…
  • Abstract Number: 1332 • ACR Convergence 2024

    Financial Distress and Its Determinants in Adults with Rheumatoid Arthritis

    Amber Brown Keebler1, Yunju Im2, Sofia Pedro3, Ted Mikuls1, Edward Peters1 and Kaleb Michaud1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Omaha, 3Forward, The National Databank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: Often not evaluated in clinical visits, financial distress associated with medical costs, also known as financial toxicity, has emerged as an important factor affecting…
  • Abstract Number: 1348 • ACR Convergence 2024

    Analysis of Body Composition in Patients with Moderate-Severe Rheumatoid Arthritis Treated with Anti-TNF Drugs

    Aimara García-Studer1, Fernando Ortiz-Márquez1, Paula Borregón-Garrido1, Arkaitz Mucientes-Ruiz1, Sara Manrique-Arija1 and Natalia Mena Vázquez2, 1Biomedical Research Institute of Malaga (IBIMA)-Bionand Platform, Department of Rheumatology, Regional University Hospital of Malaga, Malaga, Spain, 2IBIMA, Málaga, Andalucia, Spain

    Background/Purpose: Previous studies have described alterations in fat and lean mass in patients with RA, but the effect of treatments on body composition remains unclear.…
  • Abstract Number: 1364 • ACR Convergence 2024

    Machine Learning-Driven Models for Disease Activity Prediction and Therapeutic Response Evaluation in Rheumatoid Arthritis Patients: An Analysis of Data from the Multicentre, Prospective, Egyptian Collage of Rheumatology (ECR) Study Group

    Nevin Hammam1, Tarek Nahool2, A. M. Yasser3, Eman F Mohamed4, Samar Tharwat5, Doaa Mosad Mosa6, Maha Nassr7, Faten Ismail8, Rawhya R El Shereef8, Nora Y. Elsaid9, Osman Hammam10, Suzan S. Al‑Adle9 and Tamer A Gheita11, 1Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt, Boston, MA, 2University of the People, Pasadena, CA, USA, Qena, Egypt, 3Physics Department, Faculty of Science, South Valley University, Qena, Egypt; Alchemy Research, Alchemy Global Solutions, Abu Dhabi, UAE, Abu Dhabi, United Arab Emirates, 4Internal Medicine Department, Rheumatology Unit, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt, 5Rheumatology Unit, Internal Medicine, Mansoura University, Dakahlia, 6Rheumatology & Rehabilitation Department, Mansoura University Hospitals, Mansoura University Faculty of Medicine, Egypt, Dakahlia, Egypt, 7Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt, Fayoum, Egypt, 8Rheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt, 9Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, Cairo, Egypt, 10Department of Rheumatology and Rehabilitation, Faculty of Medicine, New Valley University, New Valley, Assiut, Egypt, 11Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    Background/Purpose: Rheumatoid arthritis (RA) often exhibits fluctuating and challenging-to-assess clinical courses that lead to irreversible joint destruction. However, a "Treat-to-Target" strategy is recommended aiming to…
  • Abstract Number: 1380 • ACR Convergence 2024

    Rapid, Clinically Meaningful Pain Improvements Are Associated with Improvements in Other Patient-Reported Outcomes in RA Patients Treated with Upadacitinib

    Manish Jain1, Arthur Kavanaugh2, Angela Crowley3, Avani Joshi4, Patrick Zueger5, Diane Caballero6, Andrew Garrison6 and Peter C. Taylor7, 1Endeavor Health Swedish Hospital and Captain James A, Chicago, IL, 2University of California San Diego, La Jolla, CA, 3Illinois Bone and Joint Institute, Hinsdale Orthopaedics, Hinsdale, IL, 4AbbVie, North Chicago, IL, 5AbbVie Inc, North Chicago, IL, 6AbbVie Inc., North Chicago, IL, 7University of Oxford, Oxford, United Kingdom

    Background/Purpose: Pain is a crucial symptom for patients with RA; early and effective treatment can help alleviate it.1 In this post hoc analysis, we investigated…
  • Abstract Number: 1397 • ACR Convergence 2024

    Temporal Trends in Early Rheumatoid Arthritis (ERA) Patients with Moderate to Severe Disease Activity: A Multicenter Cohort Study of Treatment Strategies and Outcomes in Chinese Patients in the Modern Era

    Yafang Deng1, Chen Yu2, Lin Qiao1, Nan Jiang1, Yanhong Wang3, Xinping Tian1, Qian Wang1, Mengtao Li4 and Xiaofeng Zeng1, 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Dong Cheng Qu, China (People's Republic), 3Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 4Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China

    Background/Purpose: In the contemporary era, the continuous update of international rheumatoid arthritis (RA) guidelines has significantly impacted the diagnosis and management of RA patients in…
  • Abstract Number: 1673 • ACR Convergence 2024

    Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States

    Chelsea Thompson1, iazsmin Ventura1, Cuoghi Edens2, Tamiko Katsumoto3 and Sowmya Popuri4, 1Section of Rheumatology, University of Chicago, Chicago, IL, 2Section of Pediatric Rheumatology, Section of Rheumatology, University of Chicago, Chicago, IL, 3Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA, 4Section of Internal Medicine, Loyola Medicine MacNeal, Maywood, IL

    Background/Purpose: In 2023, the American College of Rheumatology published a conditional recommendation for patients living with Rheumatoid Arthritis to follow a “Mediterranean style” diet. However,…
  • Abstract Number: 1747 • ACR Convergence 2024

    Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis

    Parmita Das1, Snehin Rajkumar2, Eric Yen3 and Ram Singh4, 1University of California Los Angeles, Saint Johns, 2UCLA David Geffen School of Medicine, Irvine, CA, 3UCLA, Los Angeles, CA, 4UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: Rheumatoid Arthritis (RA) is a chronic debilitating disease affecting up to 1% of the US population and has variable outcomes by race/ethnicity. We analyzed…
  • Abstract Number: 1882 • ACR Convergence 2024

    30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database

    Shobhit Piplani1, Priyanshu Jain2, Vladimir Jelic3, Clement Tagoe4 and Beverly Johnson5, 1Jacobi Medical Center/North Central Bronx Albert Einstein College of Medicine NYC Health and Hospitals, Bronx, NY, 2Jawaharlal Nehru Medical College, Belgaum, Karnataka, India, Bronx, NY, 3Jacobi Medical Center/North Central Bronx, Bronx, NY, 4Albert Einstein College of Medicine, FRESH MEADOWS, NY, 5Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Rheumatoid Arthirits (RA) is associated with heightened morbidity, diminished quality of life, and increased healthcare expenses. This research aims to bridge this gap by…
  • Abstract Number: 1968 • ACR Convergence 2024

    Development and Validation of an Arthritis-Detection Algorithm Using Thermal Imaging in Adults and Children

    Thomason Jenna1, Sullivan Erin2, Rajdeep Pooni3, Liau Adriel4, Sadie Van den Bogaerde5, Audrey Luey6, Iris Hamilton7, Sriya Paluvayi6, Megan Tran1, Janeth Robles-Navarro1, Ian Muse8, Ava Klein4, Tzielan Lee9, Grant Hughes5, Alison Bays5, Elizabeth Ferucci10, Debosmita Biswas11, Savannah Patridge11 and Yongdong (Dan) Zhao12, 1University of Washington, Division of Rheumatology, Seattle, WA, 2Biostatistics, Epidemiology, and Analytics in Research (BEAR) Core, Seattle Children’s Research Institute, Seattle, WA, 3Stanford University, Palo Alto, CA, 4Seattle Children’s Research Institute, University of Washington, Seattle, 5University of Washington, Seattle, WA, 6Seattle Children’s Research Institute, University of Washington, Seattle, WA, 7Seattle Children's Hospital, Seattle, 8Seattle Children's Research institute, Seattle, WA, 9Stanford University School of Medicine, Palo Alto, CA, 10Alaska Native Tribal Health Consortium, Anchorage, AK, 11University of Washington, Department of Radiology, Seattle, WA, 12University of Washington, Redmond, WA

    Background/Purpose: The Thermal imaging-based Temperature After Within-limb Calibration (TAWiC) algorithm for the detection of arthritis in the knees has been validated in children by our…
  • Abstract Number: 2210 • ACR Convergence 2024

    Comparison of Dual RF and Anti-CCP Seropositive, Single Seropositive, and Seronegative RA on Radiographic Changes, Flares, and Mortality

    Rebecca Brooks1, Sara Achenbach2, Vanessa Kronzer1, Elena Myasoedova1, Cynthia Crowson1 and John Davis1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, Rochester, MN

    Background/Purpose: Both RF and anti-CCP are associated with erosive disease, increased disease activity, and adverse outcomes in RA. However, there have been limited studies investigating how…
  • Abstract Number: 2228 • ACR Convergence 2024

    Feasibility, Safety, and Application for Clinical Indication and Research Purposes of Synovial Tissue Analysis in Rheumatoid Arthritis

    VAN MULLEM Cécile1, VIAILLE Charlotte1, DIERCKX Stéphanie2, NATALUCCI Francesco3, Clément triaille4, SAPART Emilie1, de MONTJOYE Stéphanie1, SOKOLOVA Tatiana1, AVRAMOVSKA Aleksandra1, NZEUSSEU TOUKAP Adrien5, MERIC de BELLEFON Laurent1 and DUREZ Patrick1, 1Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Bruxelles, Belgium, 3Sapienza University of Roma, Rheumatology, Department of Clinical, Internistic, Anesthesiological and cardiovascular sciences, Roma, Italy, 4Pôle de pathologies rhumatismales systémiques et inflammatoires, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, Brussels, Belgium, 5Institut de Recherche Expérimentale et Clinique, Cliniques universitaires Saint-Luc, Université catholique de Louvain, St.-Lambrechts-Woluwe, Belgium

    Background/Purpose: The development of ultrasound-guided synovial biopsy (US-SB) in addition to the knee mini-arthroscopy enabled synovial tissue collection from small and medium joints and facilitated molecular studies. This technique will…
  • Abstract Number: 2244 • ACR Convergence 2024

    Unveiling Synovial Protein Contributions to Serum Inflammation, Disease Activity, and Treatment Outcomes in RA Patients

    Chary Lopez-Pedrera1, Sagrario Corrales2, Julio Osuna3, Rafaela Ortega-Castro4, Jerusalén Calvo3, María Lourdes Ladehesa-Pineda1, Ismael Sánchez Pareja2, Laura Muñoz-Barrera2, Desiree Ruiz-Vilchez3, Christian Merlo5, Mª Angeles Aguirre-Zamorano6, Nuria Barbarroja2, Tomás Cerdó2, Rosa ortega3, Marta Alarcon-Riquelme7, Carlos Perez-Sanchez2, Alejandro Escudero-Contreras2 and Concepción Aranda-Valera8, 1IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Andalucia, Spain, 2IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, 4Hospital Reina Sofía, Cordoba, Andalucia, Spain, 5Rheumatology Service, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain, 6IMIBIC/Reina Sofia Hospital/University of Cordoba, CÓRDOBA, Andalucia, Spain, 7Fundación Progreso y Salud, Andalusian Government, Granada, Spain, 8IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Andalucia, Spain

    Background/Purpose: Characterize synovial tissue-secreted proteins in RA patients that contibute to serum inflammatory profiles based on immune cell infiltration.Identify RA patient subsets with distinctive serum…
  • Abstract Number: 2264 • ACR Convergence 2024

    The Risk of Malignancy and Major Adverse Cardiovascular Events with the Use of Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Real-World Evidence

    Majeed Haider1, Osama Alalwan2 and Helen Harris3, 1Salmaniya Medical Complex, Manama, Bahrain, 2Salmaniya Medical Complex, Bahrain, Bahrain, 3NHS Lothian, Western General Hospital, Edinburgh, Scotland, United Kingdom

    Background/Purpose: Tofacitinib is the first Janus Kinase Inhibitor (JAKi) approved for treating adults with rheumatoid arthritis (RA). Recently, its use has been linked to an…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 188
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology